Gilgamesh Pharma Email Format

Pharmaceutical ManufacturingNew York, United States11-50 Employees

Gilgamesh Pharma is a clinical-stage biotechnology company focused on developing therapies for psychiatric and neurological disorders. Based in New York City, it operates within the pharmaceutical manufacturing sector with a small-to-mid-sized team. The company seeks to move beyond symptom management by pursuing rapid-acting, durable treatments that address the underlying drivers of disease. Its research strategy centers on designing best-in-class new chemical entities with proven mechanisms, chosen for safety, efficacy, and patient access.

One current program is GM-3009, a derivative of ibogaine being developed for PTSD in the United States, designed to reduce cardiac side effects and currently in early-stage clinical testing. This work reflects Gilgamesh's focus on translating mechanistically grounded compounds into potential treatments for psychiatric and neurological disorders.

Sign up for free to view info

Company overview Employee directory